Breaking Finance News

Sinclair IS Pharma PLC (LON:SPH) target maintained at 63.00GBX, released a research note earlier today by Stifel

Boasting a price of 27.25GBX, Sinclair IS Pharma PLC (LON:SPH) traded 0.92% higher on the day. With the last stock price close down -15.45% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Sinclair IS Pharma PLC has recorded a 50-day average of 29.53GBX and a two hundred day average of 32.53GBX. Trading volume was up over the average, with 2,233,380 shares of SPH changing hands over the typical 673,298

Stifel hold steady the price target of Sinclair IS Pharma PLC (LON:SPH) at 63.00GBX indicating a possible upside of 1.31%.

On 9/14/2016, Stifel released a statement for Sinclair IS Pharma PLC (LON:SPH) bumped up the target price from 49.00GBX to 63.00GBX that suggested an upside of 1.32%.

Performance Chart

Sinclair IS Pharma PLC (LON:SPH)

With a market capitalization of 0 GBX, Sinclair IS Pharma PLC has with a one year low of 26.25GBX and a one year high of 61.33GBX .

A total of 4 analysts have released a report on SPH. 2 brokerages rating the stock a strong buy, one brokerage rating the company a buy, 0 brokers rating the company a hold, zero firms rating the stock a underperform, and finally zero analysts rating the company a sell with a 12-month price target of 54.25GBX.

General Information About Sinclair IS Pharma PLC (LON:SPH)

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor. The Company's product categories include Aesthetic Care, Skin Care, Wound Care and Non-Dermatology. The Company provides aesthetic dermatology solutions through thread lift, collagen stimulation and dermal fillers. The Company's aesthetic products include Silhouette Soft, Ellanse, Perfectha, Sculptra and USOFT Massage Gel. Its Silhouette Soft is inserted in the subcutaneous tissue. Its USOFT Massage Gel is a gel used for facial massage. It is engaged in research and development, and owns various product rights and licenses in a range of territories in which it trades.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.